EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF

Ekaterina Manuilova, Isabelle Schrurs, Sandra Rutz, Silja McIlwrick, Oliver Goldhardt, Patrick Sommer, Timo Grimmer iD

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70797 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ekaterina Manuilova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Roche Diagnostics GmbH, Penzberg, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins, Peptide Fragments. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Diagnostics International Ltd, Rotkreuz, Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Amyloid beta 1–42 (Aβ42), tau phosphorylated at threonine‐181 (p‐tau181), and total tau (t‐tau) are cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease diagnosis. METHODS We prospectively examined storage time, temperature, and freeze/thaw effects on Aβ42, p‐tau181, and t‐tau stability in fresh CSF samples using Elecsys ® CSF immunoassays. RESULTS All three biomarkers were stable at 2–8°C for ≤15 days, and −25°C to −15°C for ≤8 weeks, and after one freeze/thaw cycle. p‐Tau181 and t‐tau were also stable at 15–25°C for ≤8 days and at −25°C to −15°C for 12–15 weeks. Aβ42 recovery declined slightly after storage at 15–25°C for ≤8 days and −25°C to −15°C for 12–15 weeks, and one freeze/thaw cycle. DISCUSSION For optimal immunoassay performance, it is recommended to store CSF samples at 15–25°C for ≤5 days, 2–8°C for ≤15 days, and −25°C to −15°C for ≤8 weeks. Highlights Cerebrospinal fluid (CSF) biomarkers aid in Alzheimer's disease diagnosis. Fresh CSF stored at 15–25°C for ≤5 days is optimal for Elecsys CSF immunoassays. Fresh CSF stored at 2–8°C for ≤15 days is optimal for Elecsys CSF immunoassays. Fresh CSF stored at −25°C to −15°C for ≤8 weeks is optimal for Elecsys CSF immunoassays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Peptidestau ProteinsPeptide FragmentsSpecimen HandlingHumansImmunoassayBiomarkersMaleFemaleAgedPhosphorylationProspective StudiesTime FactorsTemperature

Stichwörter der Autor:innen

Alzheimer's diseaseAβ42Elecsys CSF immunoassaybiomarkersfresh CSFpre‐analytical handlingp‐tausample stabilitystorage conditionst‐tau

Substanzen

Amyloid beta-Peptidestau ProteinsBiomarkersPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Roche Diagnostics GmbH, Penzberg, Germany.
  • Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
  • Technical University of Munich (TUM), School of Medicine and Health, TUM University Hospital, Munich, Germany.

ORCID-Profile: Timo Grimmer

Förderung

  • Roche Diagnostics International Ltd, Rotkreuz, Switzerland

Zitieren

APA

Manuilova, E., Schrurs, I., Rutz, S., McIlwrick, S., Goldhardt, O., Sommer, P., & Grimmer, T. (2025). Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70797

Vancouver

Manuilova E, Schrurs I, Rutz S, McIlwrick S, Goldhardt O, Sommer P, et al. Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70797

BibTeX
@article{Manuilova2025,
  author = {Manuilova, Ekaterina and Schrurs, Isabelle and Rutz, Sandra and McIlwrick, Silja and Goldhardt, Oliver and Sommer, Patrick and Grimmer, Timo},
  title = {Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70797}
}
Kostenlos starten →